Hepatitis B Virus Reactivation during Treatment with Multi-Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma

by Shiba, Satoshi, Kondo, Shunsuke, Ueno, Hideki, Morizane, Chigusa, Ikeda, Masafumi, Okusaka, Takuji
Published 2012

Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer

by Okusaka, Takuji, Ikeda, Masafumi, Fukutomi, Akira, Ioka, Tatsuya, Furuse, Junji, Ohkawa, Shinichi, Isayama, Hiroyuki, Boku, Narikazu
Published 2014

Response to Y. Sasaki et al.: Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?

by Okusaka, Takuji, Ikeda, Masafumi, Fukutomi, Akira, Ioka, Tatsuya, Furuse, Junji, Ohkawa, Shinichi, Isayama, Hiroyuki, Boku, Narikazu
Published 2015

A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer

by Suzuki, Eiichiro, Ikeda, Masafumi, Okusaka, Takuji, Nakamori, Shoji, Ohkawa, Shinichi, Nagakawa, Tatsuya, Boku, Narikazu, Yanagimoto, Hiroaki, Sato, Tosiya, Furuse, Junji
Published 2013

Everolimus for Advanced Pancreatic Neuroendocrine Tumours: A Subgroup Analysis Evaluating Japanese Patients in the RADIANT-3 Trial

by Ito, Tetsuhide, Okusaka, Takuji, Ikeda, Masafumi, Igarashi, Hisato, Morizane, Chigusa, Nakachi, Kohei, Tajima, Takeshi, Kasuga, Akio, Fujita, Yoshie, Furuse, Junji
Published 2012

Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics

by Sunakawa, Yu, Furuse, Junji, Okusaka, Takuji, Ikeda, Masafumi, Nagashima, Fumio, Ueno, Hideki, Mitsunaga, Shuichi, Hashizume, Kensei, Ito, Yuichiro, Sasaki, Yasutsuna
Published 2013

Transarterial infusion chemotherapy with cisplatin plus S-1 for hepatocellular carcinoma treatment: a phase I trial

by Terazawa, Tetsuji, Kondo, Shunsuke, Hosoi, Hiroko, Morizane, Chigusa, Shimizu, Satoshi, Mitsunaga, Shuichi, Ikeda, Masafumi, Ueno, Hideki, Okusaka, Takuji
Published 2014

Erratum to: Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics

by Sunakawa, Yu, Furuse, Junji, Okusaka, Takuji, Ikeda, Masafumi, Nagashima, Fumio, Ueno, Hideki, Mitsunaga, Shuichi, Hashizume, Kensei, Ito, Yuichiro, Sasaki, Yasutsuna
Published 2013

Phase I study of tivantinib in Japanese patients with advanced hepatocellular carcinoma: Distinctive pharmacokinetic profiles from other solid tumors

by Okusaka, Takuji, Aramaki, Takeshi, Inaba, Yoshitaka, Nakamura, Shinichiro, Morimoto, Manabu, Moriguchi, Michihisa, Sato, Takashi, Ikawa, Yuta, Ikeda, Masafumi, Furuse, Junji
Published 2015

Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinoma

by Ikeda, Masafumi, Ohkawa, Shinichi, Okusaka, Takuji, Mitsunaga, Shuichi, Kobayashi, Satoshi, Morizane, Chigusa, Suzuki, Ikue, Yamamoto, Shunsuke, Furuse, Junji
Published 2014

Early Relapse of Unresectable Gallbladder Cancer after Discontinuation of Gemcitabine Monotherapy Administered for 5 Years in a Patient Who Had Complete Response to the Treatment

by Suyama, Koichi, Ikeda, Masafumi, Suzuki, Eiichiro, Kojima, Motohiro, Mitsunaga, Shuichi, Shimizu, Satoshi, Ohno, Izumi, Takahashi, Hideaki, Okuyama, Hiroyuki, Kuwahara, Akiko, Okusaka, Takuji, Furuse, Junji
Published 2013

Phase I study of nintedanib in Japanese patients with advanced hepatocellular carcinoma and liver impairment

by Okusaka, Takuji, Otsuka, Taiga, Ueno, Hideki, Mitsunaga, Shuichi, Sugimoto, Rie, Muro, Kei, Saito, Isao, Tadayasu, Yusuke, Inoue, Kohei, Loembé, Arsene‐Bienvenu, Ikeda, Masafumi
Published 2016

Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON

by Kudo, Masatoshi, Ikeda, Masafumi, Takayama, Tadatoshi, Numata, Kazushi, Izumi, Namiki, Furuse, Junji, Okusaka, Takuji, Kadoya, Masumi, Yamashita, Satoshi, Ito, Yuichiro, Kokudo, Norihiro
Published 2016

Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS-PC Study

by Yamaue, Hiroki, Tsunoda, Takuya, Tani, Masaji, Miyazawa, Motoki, Yamao, Kenji, Mizuno, Nobumasa, Okusaka, Takuji, Ueno, Hideki, Boku, Narikazu, Fukutomi, Akira, Ishii, Hiroshi, Ohkawa, Shinichi, Furukawa, Masayuki, Maguchi, Hiroyuki, Ikeda, Masafumi, Togashi, Yosuke, Nishio, Kazuto, Ohashi, Yasuo
Published 2015

Phase I trial of GBS‐01 for advanced pancreatic cancer refractory to gemcitabine

by Ikeda, Masafumi, Sato, Akihiro, Mochizuki, Nobuo, Toyosaki, Kayo, Miyoshi, Chika, Fujioka, Rumi, Mitsunaga, Shuichi, Ohno, Izumi, Hashimoto, Yusuke, Takahashi, Hideaki, Hasegawa, Hiromi, Nomura, Shogo, Takahashi, Ryuji, Yomoda, Satoshi, Tsuchihara, Katsuya, Kishino, Satoshi, Esumi, Hiroyasu
Published 2016

Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carc...

by Ikeda, Masafumi, Shiina, Shuichiro, Nakachi, Kohei, Mitsunaga, Shuichi, Shimizu, Satoshi, Kojima, Yasushi, Ueno, Hideki, Morizane, Chigusa, Kondo, Shunsuke, Sakamoto, Yasunari, Asaoka, Yoshinari, Tateishi, Ryosuke, Koike, Kazuhiko, Arioka, Hitoshi, Okusaka, Takuji
Published 2014

Phase I study of combination chemotherapy using sorafenib and transcatheter arterial infusion with cisplatin for advanced hepatocellular carcinoma

by Hagihara, Atsushi, Ikeda, Masafumi, Ueno, Hideki, Morizane, Chigusa, Kondo, Shunsuke, Nakachi, Kohei, Mitsunaga, Shuichi, Shimizu, Satoshi, Kojima, Yasushi, Suzuki, Eiichiro, Katayama, Kazuhiro, Imanaka, Kazuho, Tamai, Chie, Inaba, Yoshitaka, Sato, Yozo, Kato, Mina, Okusaka, Takuji
Published 2014

A phase I study of the human anti‐activin receptor‐like kinase 1 antibody PF‐03446962 in Asian patients with advanced solid tumors

by Doi, Toshihiko, Lee, Kyung‐Hun, Kim, Tae‐Min, Ohtsu, Atsushi, Kim, Tae Yong, Ikeda, Masafumi, Yoh, Kiyotaka, Gallo Stampino, Corrado, Hirohashi, Tomoko, Suzuki, Akiyuki, Fujii, Yosuke, Andrew Williams, James, Bang, Yung‐Jue
Published 2016

Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients

by Sawada, Yu, Yoshikawa, Toshiaki, Ofuji, Kazuya, Yoshimura, Mayuko, Tsuchiya, Nobuhiro, Takahashi, Mari, Nobuoka, Daisuke, Gotohda, Naoto, Takahashi, Shinichiro, Kato, Yuichiro, Konishi, Masaru, Kinoshita, Taira, Ikeda, Masafumi, Nakachi, Kohei, Yamazaki, Naoya, Mizuno, Shoichi, Takayama, Tadatoshi, Yamao, Kenji, Uesaka, Katsuhiko, Furuse, Junji, Endo, Itaru, Nakatsura, Tetsuya
Published 2016

Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placeb...

by Okita, Kiwamu, Izumi, Namiki, Ikeda, Kenji, Osaki, Yukio, Numata, Kazushi, Ikeda, Masafumi, Kokudo, Norihiro, Imanaka, Kazuho, Nishiguchi, Shuhei, Kondo, Shunsuke, Nishigaki, Yoichi, Shiomi, Susumu, Ueshima, Kazuomi, Isoda, Norio, Karino, Yoshiyasu, Kudo, Masatoshi, Tanaka, Katsuaki, Kaneko, Shuichi, Moriwaki, Hisataka, Makuuchi, Masatoshi, Okusaka, Takuji, Hayashi, Norio, Ohashi, Yasuo, Kumada, Hiromitsu
Published 2014